NASDAQ:BRTX Biorestorative Therapies (BRTX) Stock Price, News & Analysis $2.55 +0.04 (+1.59%) Closing price 09/25/2026 03:59 PM EasternExtended Trading$2.33 -0.22 (-8.78%) As of 09/25/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOwnershipSEC Filings About Biorestorative Therapies Stock (NASDAQ:BRTX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BRTX alerts:Sign Up Key Stats Today's Range$2.45▼$2.6850-Day Range$2.51▼$6.4552-Week Range$2.44▼$34.60Volume27,998 shsAverage Volume34,144 shsMarket Capitalization$3.52 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview BioRestorative Therapies, Inc. is a biotechnology company focused on developing regenerative medicine products using cell-based therapies. The company’s research programs are aimed primarily at treating musculoskeletal disorders and conditions associated with metabolic health. Its principal product candidate is BRTX-100, an autologous cell therapy being developed for painful degenerative disc disease. The treatment is designed to use a patient’s own bone marrow-derived cells, which are processed and expanded before being administered to the affected spinal disc. BioRestorative has advanced BRTX-100 through clinical development and has evaluated its safety and potential effectiveness in patients with chronic lower-back pain. The company is also developing ThermoStem, a cell therapy platform intended to generate brown adipose tissue for potential applications involving obesity and metabolic disorders. BioRestorative Therapies is based in the United States and conducts its development activities through research, clinical and regulatory programs. The company’s candidates remain subject to clinical testing and regulatory review, and their eventual availability and indications are not assured.AI Generated. May Contain Errors. Read More Biorestorative Therapies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks28th Percentile Overall ScoreBRTX MarketRank™: Biorestorative Therapies scored higher than 28% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingBiorestorative Therapies has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoverageBiorestorative Therapies has only been the subject of 1 research reports in the past 90 days.Read more about Biorestorative Therapies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Biorestorative Therapies are expected to grow in the coming year, from ($13.20) to ($10.40) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Biorestorative Therapies is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Biorestorative Therapies is -0.12, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBiorestorative Therapies has a P/B Ratio of 3.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Biorestorative Therapies' valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.97% of the float of Biorestorative Therapies has been sold short.Short Interest Ratio / Days to CoverBiorestorative Therapies has a short interest ratio ("days to cover") of 0.29, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Biorestorative Therapies has recently decreased by 69.22%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBiorestorative Therapies does not currently pay a dividend.Dividend GrowthBiorestorative Therapies does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.93 News SentimentBiorestorative Therapies has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Biorestorative Therapies this week, compared to 2 articles on an average week.MarketBeat Follows1 people have added Biorestorative Therapies to their MarketBeat watchlist in the last 30 days. Company Ownership1.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Biorestorative Therapies insiders have not sold or bought any company stock.Percentage Held by Insiders13.60% of the stock of Biorestorative Therapies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions69.38% of the stock of Biorestorative Therapies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Biorestorative Therapies' insider trading history. Receive BRTX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biorestorative Therapies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BRTX Stock News HeadlinesHead-To-Head Review: Biorestorative Therapies (NASDAQ:BRTX) versus Invivyd (NASDAQ:IVVD)September 19, 2026 | americanbankingnews.comBioRestorative Therapies consensus price target increased by 1,900% to $163.20September 16, 2026 | msn.comThe No. 1 move you need to make before Musk’s “Starphone” goes mainstreamTech forecaster Josh Baylin, who briefed Congress on the iPhone years before its release, says Elon Musk is building his most ambitious project yet: a device he calls Starphone. A new FCC ruling and last week's approval for Musk's mobile network could accelerate its launch, positioning the stocks behind it for major attention. Baylin previously flagged Palantir, Microsoft, and Apple before big runs. See which ticker he's watching now. | Stansberry Research (Ad)BioRestorative Therapies Announces Reverse Stock SplitSeptember 2, 2026 | globenewswire.comBioRestorative Therapies Halts ExoCR and BioX ShipmentsAugust 14, 2026 | tipranks.comBioRestorative Therapies Overhauls Leadership and Board GovernanceJuly 18, 2026 | theglobeandmail.comBioRestorative Therapies Updates Corporate Presentation for InvestorsJuly 15, 2026 | theglobeandmail.comBioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics PlatformJune 25, 2026 | globenewswire.comSee More Headlines BRTX Stock Analysis - Frequently Asked Questions How have BRTX shares performed this year? Biorestorative Therapies' stock was trading at $23.50 at the beginning of 2026. Since then, BRTX shares have decreased by 89.1% and is now trading at $2.55. How were Biorestorative Therapies' earnings last quarter? Biorestorative Therapies, Inc. (NASDAQ:BRTX) posted its quarterly earnings data on Thursday, May, 14th. The company reported ($3.80) earnings per share for the quarter, topping the consensus estimate of ($4.00) by $0.20. The business earned $0.02 million during the quarter, compared to the consensus estimate of $0.31 million. Biorestorative Therapies had a negative net margin of 3,088.27% and a negative trailing twelve-month return on equity of 508.42%. When did Biorestorative Therapies' stock split? Shares of Biorestorative Therapies reverse split on Wednesday, October 27th 2021.The 1-4000 reverse split was announced on Wednesday, October 27th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, October 27th 2021. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split. Is Biorestorative Therapies doing a stock buyback? Biorestorative Therapies' board authorized a stock buyback program on Tuesday, June 17th 2025, which allows the company to buy back $2,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 15.9% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's management believes its shares are undervalued. How do I buy shares of Biorestorative Therapies? Shares of BRTX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Biorestorative Therapies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biorestorative Therapies investors own include Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Actinium Pharmaceuticals (ATNM), NVIDIA (NVDA), American Graphite Technologies (AGIN). Company Calendar Last Earnings5/14/2026Today9/25/2026Next Earnings (Estimated)9/29/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (3w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 3 weeks, BRTX's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:BRTX Previous SymbolOTCMKTS:BRTXQ CIK1505497 Webwww.biorestorative.com Phone631-760-8100FaxN/AEmployees14Year Founded1997Profitability EPS (Trailing Twelve Months)($21.40) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$14.24 million Net Margins-3,088.27% Pretax Margin-3,088.27% Return on Equity-508.42% Return on Assets-230.94% Debt Debt-to-Equity RatioN/A Current Ratio2.35 Quick Ratio2.35 Sales & Book Value Annual Sales$357.87 thousand Price / Sales9.84 Cash FlowN/A Price / Cash FlowN/A Book Value$0.77 per share Price / Book3.31Miscellaneous Outstanding Shares1,381,000Free Float1,193,000Market Cap$3.52 million OptionableNot Optionable Beta0.83 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:BRTX) was last updated on 9/26/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredMy top 3 AI picks for the next decadeAlexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...The Oxford Club | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biorestorative Therapies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biorestorative Therapies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
